Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
18 Jun 24
8-K
Regulation FD Disclosure
12 Jun 24
8-K
Day One Announces Sale of Priority Review Voucher for $108 Million
30 May 24
8-K
Submission of Matters to a Vote of Security Holders
24 May 24
10-Q
2024 Q1
Quarterly report
6 May 24
8-K
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
6 May 24
8-K
Regulation FD Disclosure
24 Apr 24
ARS
2023 FY
Annual report to shareholders
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
8-K
Other Events
7 Mar 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26 Feb 24
8-K
Day One Announces Two New Appointments to Board of Directors
17 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
S-8
Registration of securities for employees
4 Jan 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
8 Dec 23
8-K
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
17 Nov 23
8-K
Changes in Registrant's Certifying Accountant
15 Nov 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
6 Nov 23
8-K
Regulation FD Disclosure
30 Oct 23
S-3ASR
Automatic shelf registration
14 Sep 23
8-K
Regulation FD Disclosure
11 Sep 23
8-K
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
16 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
7 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
23 Jun 23
8-K
Regulation FD Disclosure
12 Jun 23
8-K
Day One Announces Pricing of Public Offering of Common Stock
7 Jun 23
424B5
Prospectus supplement for primary offering
7 Jun 23
424B5
Prospectus supplement for primary offering
6 Jun 23
8-K
Other Events
6 Jun 23
8-K
Regulation FD Disclosure
5 Jun 23
10-Q
2023 Q1
Quarterly report
1 May 23
8-K
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
1 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
8-K
Regulation FD Disclosure
20 Apr 23
Latest ownership filings
4
Saira Ramasastry
21 Jun 24
144
Notice of proposed sale of securities
21 Jun 24
4
Samuel C. Blackman
12 Jun 24
144
Notice of proposed sale of securities
10 Jun 24
4
J. Scott Garland
28 May 24
4
William Grossman
28 May 24
4
Saira Ramasastry
28 May 24
4
Garry A Nicholson
28 May 24
4
John A. Josey
28 May 24
4
Natalie C. Holles
28 May 24
4
Michael Gladstone
28 May 24
4
Habib J Dable
28 May 24
4
Jeremy Bender
17 May 24
4
Samuel C. Blackman
17 May 24
4
Charles N York II
17 May 24
4
Adam Dubow
17 May 24
144
Notice of proposed sale of securities
16 May 24
144
Notice of proposed sale of securities
16 May 24
144
Notice of proposed sale of securities
16 May 24
144
Notice of proposed sale of securities
16 May 24
4
Samuel C. Blackman
14 May 24
4
Jeremy Bender
3 May 24
4
Charles N York II
3 May 24
144
Notice of proposed sale of securities
1 May 24
144
Notice of proposed sale of securities
1 May 24
4
Samuel C. Blackman
22 Apr 24
4
Samuel C. Blackman
26 Mar 24
4
Samuel C. Blackman
13 Mar 24
4
Samuel C. Blackman
28 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
Adam Dubow
20 Feb 24
4
Charles N York II
20 Feb 24
4
Samuel C. Blackman
20 Feb 24
4
Jeremy Bender
20 Feb 24
144
Notice of proposed sale of securities
16 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Atlas Venture Fund XI, L.P.
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24